WO2022201668A1 - Dispositif de traitement d'informations, système de traitement d'informations, procédé de traitement d'informations et programme - Google Patents

Dispositif de traitement d'informations, système de traitement d'informations, procédé de traitement d'informations et programme Download PDF

Info

Publication number
WO2022201668A1
WO2022201668A1 PCT/JP2021/046120 JP2021046120W WO2022201668A1 WO 2022201668 A1 WO2022201668 A1 WO 2022201668A1 JP 2021046120 W JP2021046120 W JP 2021046120W WO 2022201668 A1 WO2022201668 A1 WO 2022201668A1
Authority
WO
WIPO (PCT)
Prior art keywords
reward
user
control unit
information processing
measured value
Prior art date
Application number
PCT/JP2021/046120
Other languages
English (en)
Japanese (ja)
Inventor
大祐 西内
雅司 宇佐美
Original Assignee
テルモ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by テルモ株式会社 filed Critical テルモ株式会社
Priority to JP2023508619A priority Critical patent/JPWO2022201668A1/ja
Publication of WO2022201668A1 publication Critical patent/WO2022201668A1/fr

Links

Images

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance

Definitions

  • the present disclosure relates to an information processing device, an information processing system, an information processing method, and a program.
  • Patent Document 1 describes a configuration for predicting how blood sugar levels change due to meals and exercise.
  • the purpose of the present disclosure is to provide an information processing device, an information processing system, an information processing method, and a program that assist patients with lifestyle-related diseases to continue treatment.
  • An information processing apparatus acquires measured values of biological information considered to be relevant to a user's lifestyle habits, and the measured values measured in a predetermined measurement period are predetermined determining whether or not the determined determination condition is satisfied, and if it is determined that the measured value satisfies the determination condition, notifying the user that the restriction on the user's lifestyle habits can be relaxed. Prepare.
  • control unit updates the determination condition based on the measured value measured after notifying the user that the user's lifestyle habits can be relaxed.
  • control unit when it is determined that the measured value satisfies the determination condition, the control unit further notifies the user of actions related to lifestyle habits that can be selected by the user.
  • a first determination condition and a second determination condition are predetermined as the determination conditions, and the control unit, when it is determined that the measured value satisfies the first determination condition, The user is notified of the first behavior related to lifestyle habits selectable by the user, and if it is determined that the measured value satisfies the second determination condition, the second behavior related to lifestyle habits selectable by the user is determined. notifying the user of the action of
  • control unit acquires the measured value from a measuring device that measures the biological information of the user.
  • control unit determines whether at least one of the TIR and the average value of the measured values in the measurement period satisfies the determination condition.
  • the biological information is the blood sugar level of the user.
  • An information processing system as an embodiment of the present disclosure includes a measuring device that measures biological information considered to be relevant to a user's lifestyle, and an information processing device that can communicate with the measuring device.
  • the information processing device acquires the measured value of the biological information from the measuring device, and determines whether the measured value measured during a predetermined measurement period satisfies a predetermined determination condition. is determined, and if it is determined that the measured value satisfies the determination condition, the control unit notifies the user that the user's lifestyle habits can be relaxed.
  • a control unit of the information processing device obtains a measured value of biological information considered to be relevant to a user's lifestyle, determining whether or not the measured value measured during the measurement period satisfies a predetermined determination condition, and if it is determined that the measured value satisfies the determination condition, loosening restrictions on the user's lifestyle habits The user is notified that it is possible to do so.
  • a program for a computer as an embodiment of the present disclosure includes a process of acquiring a measured value of biological information considered to be relevant to a user's lifestyle, and the measurement measured in a predetermined measurement period. a process of determining whether or not a value satisfies a predetermined determination condition; and a process of notifying to the computer.
  • FIG. 10 is a diagram illustrating determination of a reward based on a measured value of blood sugar level
  • FIG. 10 is a diagram illustrating determination of a reward based on a measured value of blood sugar level
  • FIG. 10 is a diagram illustrating determination of a reward based on a measured value of blood sugar level
  • FIG. 10 is a diagram illustrating determination of a reward based on a measured value of blood sugar level; It is a figure which shows an example of a reward.
  • 3 is a diagram showing an example of a display screen of the patient terminal shown in FIG. 1;
  • FIG. 3 is a diagram showing an example of a display screen of the patient terminal shown in FIG. 1;
  • FIG. 3 is a flow chart showing a processing procedure of the patient terminal shown in FIG. 1;
  • 3 is a flow chart showing a processing procedure of the patient terminal shown in FIG. 1;
  • 3 is a flow chart showing a processing procedure of the patient terminal shown in FIG. 1;
  • 3 is a flow chart showing a processing procedure of the patient terminal shown in FIG. 1;
  • 2 is a flow chart showing a processing procedure of the medical staff terminal shown in FIG.
  • FIG. 1; 2 is a flow chart showing a processing procedure of the measuring device shown in FIG. 1; It is a figure which shows an example of the determination conditions of a reward.
  • 3 is a diagram showing an example of a display screen of the patient terminal shown in FIG. 1;
  • FIG. 3 is a flow chart showing a processing procedure of the patient terminal shown in FIG. 1;
  • 3 is a flow chart showing a processing procedure of the patient terminal shown in FIG. 1;
  • 3 is a flow chart showing a processing procedure of the patient terminal shown in FIG. 1;
  • 3 is a flow chart showing a processing procedure of the patient terminal shown in FIG. 1;
  • 3 is a flow chart showing a processing procedure of the patient terminal shown in FIG. 1;
  • FIG. 1 is a diagram showing a configuration example of a support system 1 as an information processing system according to one embodiment.
  • the support system 1 includes a measuring device 10 , a patient terminal 20 , a medical staff terminal 30 and a cloud 40 .
  • the measuring device 10 is a device that measures biological information considered to be relevant to the patient's (user's) 91 lifestyle. As an example of such biological information, a case in which the measuring device 10 measures the blood sugar level of the patient 91 will be described in the present embodiment.
  • the measuring device 10 is attached to the arm, abdomen, or the like of the patient 91 and measures the blood sugar level of the patient 91 in real time.
  • CGM Continuous Glucose Monitoring
  • FGM Flash Glucose Monitoring
  • a patient terminal 20 as an information processing device is a terminal device operated by a patient 91 as a user.
  • the patient terminal 20 is realized by a smart phone will be described, but it may be realized by any information processing device such as a tablet terminal or a PC (Personal Computer).
  • the patient terminal 20 receives the measured value of the blood sugar level from the measuring device 10 via a communication path such as Bluetooth, for example, and displays a screen regarding life management according to the measured value of the blood sugar level.
  • the patient 91 refers to the screen displayed on the measuring device 10 and performs life management.
  • the medical staff terminal 30 is a terminal device operated by a medical staff 92 such as a doctor or a nurse.
  • a medical staff 92 such as a doctor or a nurse.
  • the medical staff 92 operates the medical staff terminal 30 to set information such as criteria for determining the reward to be applied to the patient 91 and details of the reward.
  • the cloud 40 communicates with the patient terminal 20 and the medical staff terminal 30 to provide the measured value of biological information such as blood sugar level, the determination condition of the reward, the content of the reward, the reward selected by the patient 91, etc. is an information processing device that manages the information of The cloud 40 may be realized by an information processing device such as a WS (WorkStation) or a PC.
  • the cloud 40 communicates with the patient terminal 20 and the medical staff terminal 30 using the Internet or a carrier network, etc., and communicates with these terminals the measured values of biological information such as blood sugar levels, and the reward determination conditions described later. , content of the reward, and information such as the reward selected by the patient 91 are synchronized.
  • the patient 91 has diabetes, and as part of its treatment, he receives guidance from a medical worker 92 regarding life management such as calorie intake, carbohydrate restriction, and exercise, and is implementing it.
  • life management such as calorie intake, carbohydrate restriction, and exercise
  • the patient terminal 20 displays a display for permitting relaxation with a reduced intensity of treatment as a reward.
  • the reward is, for example, permission to eat a staple food with less carbohydrate restriction, snacks between meals, and a reduction in exercise intensity.
  • the patient terminal 20 increases and maintains the patient's 91 motivation for treatment, and prevents interruption of treatment. Therefore, according to this embodiment, it is possible to support the continuation of the treatment of the patient 91 .
  • FIG. 2 is a diagram showing a configuration example of the measuring device 10 shown in FIG.
  • the measurement device 10 includes a control section 11 , a clock 12 , a sensor 13 , a measurement section 14 , a communication section 15 , a storage section 16 and a power supply section 17 .
  • the control unit 11 is one or more processors.
  • the control unit 11 is realized by a dedicated processor specialized for processing such as measuring the blood sugar level of the patient 91 and communicating with the patient terminal 20 via the communication unit 15, but a general-purpose processor such as a CPU (Central Processing Unit) It may be implemented by a processor.
  • Control unit 11 may include one or more dedicated circuits, or one or more processors may be replaced by one or more dedicated circuits in control unit 11 .
  • the dedicated circuit is, for example, an FPGA (Field-Programmable Gate Array) or an ASIC (Application Specific Integrated Circuit).
  • the control unit 11 controls each unit of the measuring device 10 and executes information processing related to the operation of the measuring device 10 .
  • a clock 12 is a clock generation circuit that generates a clock signal that defines the timing of each operation of the measuring device 10 .
  • Clock 12 is implemented by, for example, a crystal oscillator, but may also be implemented on a silicon basis.
  • the clock 12 may be provided inside the control unit 11, for example.
  • the sensor 13 is a detection device that measures the blood sugar level of the patient 91 .
  • the sensor 13 for example, reacts glucose in the interstitial fluid of the subcutaneous tissue of the patient 91 with glucose oxidase enzyme to convert it into an electrical signal, and outputs the electrical signal to the measurement unit 14 .
  • the measurement unit 14 measures the glucose concentration in the interstitial fluid based on the electrical signal output from the sensor 13. Thereby, the blood sugar level of the patient 91 is measured.
  • the communication unit 15 is a communication interface for communicating with the patient terminal 20.
  • the communication unit 15 communicates with the patient terminal 20 and transmits the blood glucose level measured by the sensor 13 and the measurement unit 14 to the patient terminal 20 .
  • the communication unit 15 communicates with the patient terminal 20 via, for example, Bluetooth, but is not limited to this, and may communicate via other wireless communication paths such as a wireless LAN (Local Area Network) or a wired cable.
  • the storage unit 16 includes arbitrary storage modules including, for example, RAM (Random Access Memory) and ROM (Read-Only Memory).
  • the storage unit 16 may function, for example, as a main storage device or a cache memory that stores information such as measured values of blood sugar levels.
  • the storage unit 16 stores arbitrary information used for the operation of the measuring device 10 .
  • the storage unit 16 may store system programs, application programs, various information received by the communication unit 15, and the like.
  • the power supply unit 17 provides power for driving the measuring device 10 .
  • the power supply unit 17 may be implemented by a rechargeable battery such as a lithium ion battery.
  • FIG. 3 is a diagram showing a configuration example of the patient terminal 20 shown in FIG.
  • the patient terminal 20 includes a control section 21 , a storage section 22 , a communication section 23 , an input section 24 and an output section 25 .
  • the control unit 21 is one or more processors.
  • the processor is a general-purpose processor such as a CPU or GPU (Graphics Processing Unit), or a dedicated processor specialized for specific processing.
  • the controller 21 may include one or more dedicated circuits, or one or more processors may be replaced with one or more dedicated circuits in the controller 21 .
  • a dedicated circuit is, for example, an FPGA or an ASIC.
  • the control unit 21 controls each unit of the patient terminal 20 and executes information processing related to the operation of the patient terminal 20 .
  • the storage unit 22 is one or more semiconductor memories, one or more magnetic memories, one or more optical memories, or a combination of at least two of them.
  • a semiconductor memory is, for example, a RAM or a ROM.
  • RAM is, for example, SRAM (Static RAM) or DRAM (Dynamic RAM).
  • the ROM is, for example, an EEPROM (Electrically Erasable Programmable ROM).
  • the storage unit 22 functions, for example, as a main memory device, an auxiliary memory device, or a cache memory.
  • the storage unit 22 stores information used for the operation of the patient terminal 20, information obtained by the operation of the patient terminal 20, and the like.
  • the communication unit 23 is one or more communication interfaces.
  • the communication interface is a wired LAN interface, a wireless LAN interface, a Bluetooth communication interface, or the like.
  • the communication unit 23 receives information used for the operation of the patient terminal 20 and transmits information obtained by the operation of the patient terminal 20 .
  • the measured value of the blood sugar level of the patient 91 is received from the measuring device 10, and the measured value of biological information such as the blood sugar level, the determination condition of the reward, the content of the reward, And information such as a reward selected by the patient 91 is transmitted and received.
  • the input unit 24 includes one or more input interfaces that receive input operations by the patient 91 and acquire input information based on the patient's 91 operations.
  • the input unit 24 is, for example, a physical key, a capacitive key, a pointing device, a touch screen provided integrally with the display of the output unit 25, or a microphone that accepts voice input, but is not limited to these.
  • the output unit 25 includes one or more output interfaces for outputting information to the patient 91 and notifying the patient 91 .
  • the output unit 25 is a display or the like that outputs information as an image, but is not limited to this.
  • the functions of the patient terminal 20 are realized by executing the program (computer program) according to the present embodiment by the processor included in the control unit 21. That is, the functions of the patient terminal 20 are implemented by software.
  • the program causes the computer to execute the processing of steps included in the operation of the patient terminal 20, thereby causing the computer to implement the functions corresponding to the processing of the steps. That is, the program is a program for causing the computer to function as the patient terminal 20 .
  • the program can be recorded on a computer-readable recording medium.
  • a computer-readable recording medium is, for example, a magnetic recording device, an optical disk, a magneto-optical recording medium, or a semiconductor memory.
  • Program distribution is performed by selling, assigning, or lending a portable recording medium such as DVD (Digital Versatile Disc) or CD-ROM (Compact Disc Read Only Memory) on which the program is recorded.
  • the program may be distributed by being stored in the storage of the server and being transferred from the server to another computer via the network.
  • a program may be provided as a program product.
  • a computer temporarily stores a program recorded on a portable recording medium or a program transferred from a server in a main storage device. Then, the computer reads the program stored in the main storage device with the processor, and executes processing according to the read program with the processor.
  • the computer may read the program directly from the portable recording medium and execute processing according to the program.
  • the computer may execute processing according to the received program every time the program is transferred from the server to the computer. Processing may be executed by a so-called ASP (Application Service Provider) type service that implements functions only by executing instructions and obtaining results without transferring a program from a server to a computer.
  • the program includes information corresponding to the program, which is information used for processing by the computer. For example, data that is not a direct command to a computer, but has the property of prescribing computer processing, corresponds to "program-based information".
  • a part or all of the functions of the patient terminal 20 may be realized by a dedicated circuit included in the control unit 21. That is, part or all of the functions of the patient terminal 20 may be realized by hardware. Moreover, the patient terminal 20 may be realized by a single information processing device, or may be realized by cooperation of a plurality of information processing devices.
  • FIG. 4 is a diagram showing a configuration example of the medical staff terminal 30 shown in FIG.
  • the medical staff terminal 30 includes a control unit 31 , a storage unit 32 , a communication unit 33 , an input unit 34 and an output unit 35 .
  • Functions and roles of the control unit 31, the storage unit 32, the communication unit 33, the input unit 34, and the output unit 35 of the medical staff terminal 30 are the same as those of the control unit 21, the storage unit 22, the communication unit 23, and the input unit of the patient terminal 20. 24 and the output unit 25, and detailed description thereof will be omitted.
  • the functions of the medical staff terminal 30 are implemented by software, some or all of the functions may be implemented by hardware.
  • the medical staff terminal 30 may be realized by a single information processing device, or may be realized by cooperation of a plurality of information processing devices.
  • the cloud 40 may be implemented by an information processing device such as a WS or PC, and may be implemented by a configuration equivalent to the configuration of the medical staff terminal 30 shown in FIG. Although the functions of the cloud 40 are implemented by software, some or all of the functions may be implemented by hardware. Further, the cloud 40 may be realized by a single information processing device, or may be realized by cooperation of a plurality of information processing devices.
  • FIG. 5 is a diagram showing an overview of reward presentation by the support system 1.
  • the patient 91 always wears the measuring device 10 during the treatment using the support system 1 according to this embodiment.
  • the measuring device 10 measures the blood sugar level of the patient 91 at predetermined measurement intervals, for example, every five minutes.
  • the measuring device 10 transmits the measured value of the blood glucose level to the patient terminal 20 at a timing when communication with the patient terminal 20 is possible.
  • the patient terminal 20 automatically uploads the measured value of the blood sugar level to the cloud 40 at a timing when communication with the cloud 40 is possible, such as while the patient terminal 20 is connected to a carrier line, the Internet, or the like.
  • the medical staff terminal 30 automatically downloads the measured value of the blood sugar level from the cloud 40 at the timing when communication with the cloud 40 is possible, and obtains the measured value of the blood sugar level of the patient 91 .
  • the patient terminal 20 treats the patient 91 based on the blood glucose level measured from the 1st day to the 5th day in the reward cycle, with 7 days as one reward cycle. It is determined whether or not to give a reward, and if so, what kind of reward is to be given. These determination conditions are set in advance by medical staff 92 who examines patient 91 . The patient terminal 20 displays the determination result on the output unit 25 . In the example of FIG. 5, the period during which the reward can be implemented is set on the 6th day of each reward cycle.
  • the medical staff 92 may refer to the measured value of the blood sugar level notified to the medical staff terminal 30 via the cloud 40 to correct the reward determination conditions and the like.
  • the patient terminal 20 may automatically correct the reward determination conditions and the like according to a rule preset by the medical staff 92 or the like.
  • the content of the correction may be, for example, as follows. - The reward selected by the patient 91 cannot be selected from the next time onwards.
  • a reward cycle such as that in FIG. 5 is an example, for example, a reward cycle could be for a longer period such as 10 days, 2 weeks, or 1 month, or for a shorter period such as 5 days. may Also, for example, the period during which the reward can be implemented may be a longer period such as two days. Further, for example, the correction of the reward determination conditions may be performed not only on the day after the reward is available, but also on any date and time.
  • FIG. 6 is a diagram showing an example of reward determination conditions.
  • the patient terminal 20 uses TIR (Time in Range) of the blood sugar level as an example of an index for determining the reward.
  • TIR refers to the number of measurements or time during which the measured blood glucose level is within the therapeutic range (Target Range, eg, 70 to 180 mg/dL) during the measurement target period.
  • the range of blood sugar levels is set to (1) a range greater than 250 mg/dL, (2) a range greater than 180 mg/dL and 250 mg/dL or less, and (3) 180 mg/dL. Divide into three ranges (TIR bins) for the range below dL.
  • the patient terminal 20 determines the reward based on the number of measured values included in each range or the percentage of time.
  • the "recommended ratio" in FIG. 6 indicates how the blood sugar level of the patient 91 should preferably be distributed in each range of (1) to (3).
  • the recommended ratio is, for example, as shown in FIG. 6, (1) the ratio of measured values belonging to the range greater than 250 mg / dL is less than 5%, and (2) the range is greater than 180 mg / dL and 250 mg / dL or less. The percentage of measured values may be less than 25%, and (3) the percentage of measured values belonging to the range of 180 mg/dL or less may be greater than 75%. If the patient's 91 blood glucose measurements are distributed in proportions better than such recommended proportion requirements, the patient terminal 20 provides a reward accordingly.
  • three grades of reward 1 to reward 3 are defined as an example of blood sugar level conditions for giving rewards.
  • the grades of the three rewards are reward 1, reward 2, and reward 3, with reward 1 being given when the blood sugar value is the best.
  • the determination ratio of reward 1 is that (1-1) the ratio of measured values belonging to a range larger than 250 mg / dL to all measured values is less than 5%, and (1-2) is higher than 180 mg / dL.
  • the measured value belonging to the range of 150 mg/dL or less is 70% or more of the measured value belonging to the range of 180 mg/dL or less.
  • Reward 2 judgment percentage is (2-1) less than 5% of all measured values belonging to a range greater than 250 mg/dL, (2-2) greater than 180 mg/dL and 250 mg/dL or less.
  • Reward 3 judgment percentage is (3-1) less than 5% of all measured values belonging to a range greater than 250 mg/dL, (3-2) greater than 180 mg/dL and 250 mg/dL or less. less than 25% of all measured values, and (3-3) more than 80% of all measured values in the range of 180 mg/dL or less. If a high grade reward is obtained, the patient 91 can also choose from lower grade rewards. For example, if the patient 91 gets Reward 1, he or she can also choose from the lower Reward 2 or Reward 3.
  • FIG. 7A to 7C are diagrams explaining determination of a reward based on the measured blood sugar level.
  • FIG. 7A shows that the ratio of measured values belonging to the range of greater than 250 mg/dL to the total measured values is 2%, and the measured values belonging to the range of greater than 180 mg/dL and 250 mg/dL or less are all measured.
  • An example is shown in which the ratio to the value is 30%, and the ratio of the measured values belonging to the range of 180 mg/dL or less to the total measured values is 68%.
  • the measurements in this example satisfy both the recommended rate and rewards 1-3 requirements for ranges greater than 250 mg/dL. However, the measured values in this example do not meet the requirements of either the recommended rate or Rewards 1-3 for the range below 250 mg/dL. Therefore, the patient terminal 20 displays, for example, that good blood sugar control has not been achieved.
  • FIG. 7B shows that the ratio of the measured values belonging to the range greater than 250 mg/dL to the total measured values is 3%, and the measured values belonging to the range greater than 180 mg/dL and 250 mg/dL or less are all measured.
  • An example is shown in which the ratio to the value is 21%, and the ratio of the measured values belonging to the range of 180 mg/dL or less to the total measured values is 76%.
  • the measured value in this example satisfies both the recommended rate and rewards 1-3 requirements for the range greater than 250 mg/dL and the range greater than 180 mg/dL and less than or equal to 250 mg/dL.
  • the measured value in this example meets the requirements of the recommended rate for the range of 180 mg/dL and below, but does not meet the requirements of Rewards 1-3. Therefore, the patient terminal 20 displays, for example, that good blood sugar control has been achieved without giving a reward.
  • FIG. 7C shows that the ratio of the measured values belonging to the range greater than 250 mg/dL to the total measured values is 2%, and the measured values belonging to the range greater than 180 mg/dL and 250 mg/dL or less are all measured. 14% of measured values, 84% of measured values belonging to the range of 180 mg/dL or less to all measured values, ratio of measured values belonging to the range of 150 mg/dL or less to measured values belonging to the range of 180 mg/dL or less is 75%.
  • the measured value of this example satisfies all the requirements of the recommended ratio and Rewards 1 to 3 for the ratio of measured values in any range. Therefore, the patient terminal 20 displays that the reward 1 is given.
  • FIG. 8 is a diagram showing an example of rewards for each grade.
  • the patient 91 selects "one donut", “five cookies”, “staple food (carbohydrate 20% increase) once", and "reduced amount of exercise”. (walking 5,000 steps/day)” can be selected and executed.
  • reducing the amount of exercise means reducing the amount of exercise (for example, reducing the amount of exercise by 50%) compared to the amount of exercise in normal exercise therapy.
  • Increasing carbohydrates in a staple food means increasing carbohydrates in a normal carbohydrate-restricted diet (for example, by 20%).
  • the patient 91 selects “one donut + less exercise (walking 5,000 steps/day)", “five cookies + less exercise (walking 5,000 steps/day)", “ Select and execute either staple food (carbohydrate 20% increase) once + reduced exercise (walking 5,000 steps/day) or reduced exercise (walking 1,000 steps/day). can be done.
  • the patient 91 receives "two donuts + reduced exercise (walking 5,000 steps/day) + oral hypoglycemic agent”, “10 cookies + reduced exercise (walking 5,000 steps/day). day) + oral hypoglycemic agent” or “staple food (40% increase in carbohydrates) once + reduced exercise (walking 5,000 steps/day) + oral hypoglycemic agent”.
  • the oral hypoglycemic agent is administered, for example, in combination with a main meal or a snack, and is administered as a safety measure by a doctor in consideration of the patient's pathology, the patient's past selection results, and subsequent blood sugar rise.
  • the content of the reward takes into consideration the condition and preferences of the patient 91, as well as the prior questionnaire to the patient 91 and the past selection results of the patient 91, etc. and carbohydrate limit, amount of exercise, etc.).
  • the conditions for judging rewards in FIG. 6 are just an example, and criteria other than those shown in FIG. may be selected.
  • criteria other than those shown in FIG. may be selected.
  • the example of FIG. 6 specifies three grades of rewards, there may be fewer or more than three grades of rewards.
  • a range other than the numerical range illustrated in FIG. 6 may be selected as the determination ratio of the measured values.
  • the reward in FIG. 8 is also an example, and another reward may be selected according to the condition and taste of the patient 91, nutritional components of food, and the like.
  • FIG. 9 is a diagram showing an example of the display screen of the patient terminal 20 shown in FIG.
  • the display serving as the output unit 25 displays information regarding changes in the blood sugar level of the patient 91, rewards, and the like.
  • the output unit 25 displays a trend graph 51 showing the time transition of the blood sugar level, the latest measured value 52 of the blood sugar level, and a scroll bar 53 for scrolling the trend graph 51 on the output unit 25 .
  • the output unit 25 also displays a TIR observation period 54 , a TIR measurement value ratio 55 , and a scroll bar 56 for scrolling the TIR measurement value ratio 55 .
  • the output unit 25 also displays a display area 57 for information related to the reward and an alert box 61 presenting a message to the patient 91 .
  • a reward selection button 60 is displayed in the display area 57 when there is a reward.
  • the patient terminal 20 displays a reward selection screen.
  • FIG. 10 is a diagram showing an example of a screen displayed on the output unit 25 of the patient terminal 20 in response to pressing of the reward selection button 60.
  • FIG. 10 shows an example of the screen when it is decided to give the reward 2.
  • the selection button 63 for the reward 1 cannot be selected, and the selection button 64 for the reward 2 and the selection button 65 for the reward 3 with a lower grade than the reward 2 are displayed so as to be selectable.
  • the patient terminal 20 accepts selection of a specific reward (for example, "one donut").
  • the patient terminal 20 displays the selected reward 58 and the reward execution time limit 59 in the display area 57 .
  • FIGS. 11A to 11D are flow charts showing an operation example of the patient terminal 20 shown in FIG.
  • the operation of the patient terminal 20 described with reference to FIGS. 11A to 11D corresponds to the information processing method according to this embodiment.
  • 11A to 11D are executed under the control of the control section 21.
  • step S ⁇ b>1 the control unit 21 establishes wireless communication with the measuring device 10 .
  • step S2 the control unit 21 resets the reward cycle and the TIR bin frequency (the number of measured values). This sets the number of days elapsed to the first day of the 7-day reward cycle. Also, the frequency of measurements in each TIR bin of (1) the range greater than 250 mg/dL, (2) the range greater than 180 mg/dL and 250 mg/dL or less, and (3) the range 180 mg/dL or less is 0. is set to
  • step S3 the control unit 21 determines whether the measuring device 10 stores a measured value that the patient terminal 20 has not yet received. This determination is made by querying the measuring device 10, but is not limited to this. For example, the control unit 21 pays attention to the fact that the blood sugar level is measured at predetermined measurement intervals (for example, every 5 minutes), and the measurement interval has elapsed since the measurement time of the previously acquired measurement value. The presence or absence of unreceived measurements may be determined based on whether the If there is a measurement value that has not yet been received (YES in step S3), the control unit 21 proceeds to step S4, otherwise (NO in step S3), continues the processing of S3.
  • predetermined measurement intervals for example, every 5 minutes
  • step S ⁇ b>4 the control unit 21 receives measurement values that have not yet been received from the measuring device 10 and stores them in the storage unit 22 .
  • step S5 the control unit 21 causes the output unit 25 to display the received measured value as the latest measured value 52, and updates the trend graph 51.
  • step S6 the control unit 21 determines which TIR bin (1) to (3) the received measurement value belongs to.
  • step S7 the control unit 21 increases the frequency of the determined TIR bin by one.
  • the control unit 21 performs the processing of steps S5 and S6 for each of the received measured values.
  • step S8 the control unit 21 determines whether or not a predetermined period has elapsed since the start of the reward cycle.
  • the predetermined period here is a period of time determined by the timing of updating the display of the TIR observation period 54 and the TIR measurement value ratio 55 of the output section 25 .
  • the predetermined period in step S8 is 24 hours, 48 hours, 72 hours, and so on. be. If the predetermined period has elapsed from the start of the reward cycle (YES in step S8), the control section 21 proceeds to step S9, otherwise (NO in step S8), returns to step S3.
  • step S9 the control unit 21 calculates the TIR acquired during the predetermined period, updates the display of the TIR observation period 54, and updates the display of the TIR measurement value ratio 55 based on the calculated TIR.
  • step S10 the control unit 21 determines whether 1 day, 2 days, 3 days, or 4 days have passed since the start of the reward cycle, that is, 24 hours, 48 hours, or 72 hours from the start of the reward cycle. , or whether or not 96 hours have elapsed. If 1 day, 2 days, 3 days, or 4 days have passed (YES in step S10), the control unit 21 returns to step S3, otherwise (NO in step S10), proceeds to step S11.
  • step S11 the control unit 21 determines whether five days have passed since the start of the reward cycle, that is, whether 120 hours have passed since the start of the reward cycle. If five days have passed (YES in step S11), control unit 21 proceeds to step S12, otherwise (NO in step S11), proceeds to step S28.
  • step S12 the control unit 21 determines whether the TIR calculated in step S9 satisfies the recommended ratio described with reference to FIG.
  • the TIR is the measurement ratio that reflects the measurements from day 1 through day 5 of the reward cycle. If the recommended ratio is satisfied (YES in step S12), the control unit 21 proceeds to step S14, otherwise (NO in step S12), proceeds to step S13.
  • step S13 the control unit 21 displays in the alert box 61 that good blood sugar control has not been achieved, for example, "You are one step away from good blood sugar control.” And the control part 21 returns to step S3.
  • step S14 the control unit 21 determines whether the changed reward list exists in the cloud 40. That is, the control unit 21 communicates with the cloud 40, compares the reward list stored in the storage unit 22 of the patient terminal 20, and the reward list stored in the cloud 40, and if they are different, The control unit 21 determines that there is a changed reward list. If there is a changed reward list (YES in step S14), the control unit 21 proceeds to step S15, otherwise (NO in step S14), proceeds to step S16.
  • step S15 the control unit 21 downloads the changed reward list from the cloud 40 and updates (updates) the reward list stored in the storage unit 22. If the patient terminal 20 cannot communicate with the cloud 40, for example, because the patient terminal 20 is out of the carrier communication range, the process of step S15 may be omitted.
  • step S16 the control unit 21 determines whether the TIR calculated in step S9 satisfies the determination ratio of the reward 1 described with reference to FIG. If the determination ratio of reward 1 is satisfied (YES in step S16), the control unit 21 proceeds to step S17, otherwise (NO in step S16), proceeds to step S18.
  • step S17 the control unit 21 displays in the alert box 61 that a reward 1 will be given, for example, "Good control is possible. There is a reward 1.” And the control part 21 progresses to step S23.
  • step S18 the control unit 21 determines whether the TIR calculated in step S9 satisfies the determination ratio of reward 2 described with reference to FIG. If the determination ratio of the reward 2 is satisfied (YES in step S18), the control unit 21 proceeds to step S19, otherwise (NO in step S18), proceeds to step S20.
  • step S19 the control unit 21 displays in the alert box 61 that a reward 2 will be given, for example, "Good control is possible. There is a reward 2.” And the control part 21 progresses to step S23.
  • step S20 the control unit 21 determines whether or not the TIR calculated in step S9 satisfies the determination ratio of reward 3 described with reference to FIG. If the determination ratio of the reward 3 is satisfied (YES in step S20), the control unit 21 proceeds to step S21, otherwise (NO in step S20), proceeds to step S22.
  • step S21 the control unit 21 displays in the alert box 61 that a reward 3 will be given, for example, "Good control is possible. There is a reward 3.” And the control part 21 progresses to step S23.
  • step S22 the control unit 21 notifies the alert box 61 that good blood sugar control has been achieved without giving a reward such as, for example, "Good blood sugar control is achieved. You are one step away from the reward.” to display. And the control part 21 returns to step S3.
  • step S23 the control unit 21 displays a reward selection button 60 in the display area 57 for information related to rewards.
  • step S24 the control unit 21 determines whether or not the reward selection button 60 has been selected by the patient 91. If selected (YES in step S24), the process proceeds to step S25; otherwise (NO in step S24), the process of step S24 is performed again. If the reward selection button 60 is not selected by the patient 91, the controller 21 may proceed to step S3.
  • step S25 the control unit 21 displays the corresponding reward list on the output unit 25.
  • step S26 the control unit 21 determines whether or not the patient 91 has selected a reward. If selected (YES in step S26), the process proceeds to step S27; otherwise (NO in step S26), the process of step S26 is performed again. If the patient 91 does not select a reward, the controller 21 may proceed to step S3.
  • step S27 the control unit 21 displays the reward 58 selected by the patient 91 and the reward implementation deadline 59 in the display area 57 of the information related to the reward. And the control part 21 returns to step S3.
  • step S28 the control unit 21 determines whether 6 days have passed since the start of the reward cycle, that is, whether 144 hours have passed since the start of the reward cycle. If only six days have passed (YES in step S28), the control unit 21 proceeds to step S29, otherwise, that is, if only seven days have passed (NO in step S28), the process proceeds to step S31.
  • step S29 the control unit 21 determines whether the patient 91 has obtained a reward. The control unit 21 determines that the reward has been obtained when any of the rewards 1 to 3 is given at the timing when only five days have passed since the start of the reward cycle. If a reward has been obtained (YES in step S29), control unit 21 proceeds to step S30, otherwise (NO in step S29), returns to step S3.
  • step S ⁇ b>30 the control unit 21 hides the display area 57 of information related to the reward in the output unit 25 . And the control part 21 returns to step S3.
  • step S31 the control unit 21 determines whether the TIR calculated in step S9 satisfies the recommended ratio described with reference to FIG.
  • This TIR is a measured value ratio that reflects the measured values from the first day to the seventh day of the reward cycle, and the effect of giving the reward is taken into consideration. If the recommended ratio is satisfied (YES in step S31), the control unit 21 proceeds to step S32, otherwise (NO in step S31), proceeds to step S33.
  • step S32 the control unit 21 displays in the alert box 61 that good blood sugar control has been achieved, such as "Good blood sugar control.” And the control part 21 returns to step S2.
  • step S33 the control unit 21 determines whether the patient 91 has obtained a reward.
  • the control unit 21 determines that the reward has been obtained when any of the rewards 1 to 3 is given at the timing when only five days have passed since the start of the reward cycle. If a reward has been obtained (YES in step S33), the control unit 21 proceeds to step S35, otherwise (NO in step S33), proceeds to step S34.
  • the processing from step S34 onwards is executed when the TIR does not meet the recommended ratio even though seven days have passed without any reward being given.
  • the processing after step S35 is performed when the TIR is good from the first day to the 5th day of the reward cycle and the reward is given, but the blood sugar level rises by the 7th day and the TIR does not satisfy the recommended ratio. is executed.
  • step S34 the control unit 21 displays in the alert box 61 that good blood sugar control has not been achieved, for example, "You are one step away from good blood sugar control.” And the control part 21 returns to step S2.
  • step S35 the control unit 21 corrects the reward list stored in the storage unit 22.
  • the control unit 21 updates the contents of each of the rewards 1 to 3 with contents that are considered to further suppress the increase in the blood sugar level.
  • the control unit 21 reduces the amount of increase in sugar allowed in the staple food, changes the snacks to foods with lower calories, and reduces the amount of decrease in exercise intensity. You can make it smaller.
  • the control unit 21 may, for example, replace the content of the reward 1 with the content of the reward 2, replace the content of the reward 2 with the content of the reward 3, and modify so as not to give the reward 3. .
  • step S36 the control unit 21 uploads the relevant data to the cloud 40 and notifies the doctor in charge (medical worker 92) that the TIR no longer satisfies the recommended ratio after giving the reward.
  • the relevant data here are the TIR, the measured value, the content of the reward selected by the patient 91, and the like.
  • the notification to medical personnel 92 is done via the cloud 40, but may be done by another method such as e-mail.
  • step S37 the control unit 21 says, "You were one step away from good blood sugar control. The reward conditions have been changed, so please consult your doctor.” An alert box 61 is displayed to the effect that consultation is recommended. And the control part 21 returns to step S2.
  • FIG. 12 is a flow chart showing an operation example of the medical staff terminal 30 shown in FIG. The operation of each step in FIG. 12 is executed under the control of the control section 31 .
  • step S41 the control unit 31 connects to the cloud 40 so that it can communicate with it.
  • step S42 the control unit 31 determines whether or not there is a notification that the reward list has been corrected. This notification is made when the TIR no longer satisfies the recommended ratio after the award of the reward. If the reward list has been corrected (YES in step S42), the control unit 31 proceeds to step S43, otherwise continues the process of step S42. If the reward list has not been corrected, the control unit 31 may display that fact on the display as the output unit 35 and end the processing of the flowchart.
  • step S43 the control unit 31 displays the related data on the output unit 35.
  • This relevant data includes TIR, measurements, reward lists, and rewards selected by patient 91 .
  • step S44 the control unit 31 determines whether or not to approve the revised reward list.
  • the control unit 31 determines whether or not to approve based on whether or not the medical staff 92 has input an approval instruction. If the control unit 31 approves (YES in step S44), it ends the processing of the flowchart, and if it does not approve (NO in step S44), it proceeds to step S45.
  • step S45 the control unit 31 performs processing to change the corrected reward list.
  • the control unit 31 changes the reward list according to the instruction input by the medical staff 92 .
  • step S46 the control unit 31 uploads the changed reward list to the cloud 40.
  • the reward list uploaded to the cloud 40 is transmitted to the patient terminal 20 and reflected in the patient terminal 20 at a timing when communication between the cloud 40 and the patient terminal 20 is possible. Then, the control unit 31 ends the processing of the flowchart.
  • FIG. 13 is a flow chart showing an operation example of the measuring device 10 shown in FIG. The operation of each step in FIG. 13 is executed under the control of the control section 11 .
  • step S51 the control unit 11 connects to the patient terminal 20 so that it can communicate with it.
  • step S52 the control unit 11 starts measuring the blood sugar level of the patient 91.
  • step S53 the control unit 11 determines whether or not the sampling cycle has been reached. For example, when measuring every 5 minutes, it is determined whether 5 minutes have passed. If the control unit 11 determines that the sampling period has been reached (YES in step S53), the process proceeds to step S54, and if not, the process of step S53 is repeated.
  • step S54 the control unit 11 transmits the measured value to the patient terminal 20. Then, the control unit 11 terminates the processing of the flowchart.
  • FIG. 13 shows an example in which the blood glucose level of the patient 91 is measured when the measuring device 10 is connected to the patient terminal 20. It is not limited only when For example, the measuring device 10 measures the blood glucose level even while not connected to the patient terminal 20, stores the measurement results in the storage unit 16, and stores the measurement results in the storage unit 16 when communication with the patient terminal 20 becomes possible. The stored measurement results may be collectively transmitted to the patient terminal 20 .
  • the patient terminal 20 acquires the measured values of biological information considered to be relevant to the user's lifestyle habits, and the measured values measured during the predetermined measurement period meet the predetermined judgment conditions. It is determined whether or not the condition is satisfied. When it is determined that the measured value satisfies the determination conditions, the patient terminal 20 notifies the user that the user's lifestyle habits can be relaxed. In this way, by notifying the user that restrictions on the user's lifestyle habits can be relaxed based on the measured values of the user's biological information, the patient's motivation for treatment is enhanced and maintained, and treatment is interrupted. can be prevented. Therefore, according to this embodiment, it is possible to support the continuation of the treatment of the patient 91 .
  • a blood sugar level as biological information that is considered to be relevant to the user's lifestyle has been described. good too. Further, in the present embodiment, an example has been described in which the user is notified that the user's lifestyle habits can be relaxed by displaying a message on the output unit 25 of the patient terminal 20. It may be notified that the restrictions on lifestyle habits can be relaxed.
  • the patient terminal 20 updates the determination conditions based on the measured values after notifying the user that the restrictions on the user's lifestyle habits can be relaxed. Therefore, for example, as a result of loosening restrictions on lifestyle habits, if the measured values of biological information worsen more than expected, such as a significant increase in blood sugar levels, the conditions for loosening restrictions on lifestyle habits will be stricter, and the patient will 91 can be used for treatment.
  • the measured values of biometric information deteriorate more than expected has been described. If not, the conditions for loosening restrictions on lifestyle habits may be relaxed. As a result, the user's lifestyle is not restricted more than necessary, making it easier for the user to continue treatment.
  • the patient terminal 20 when it is determined that the measured value satisfies the determination conditions, the patient terminal 20 further notifies the user of behavior (reward) related to lifestyle habits that the user can select. Therefore, it is possible for the user to understand specifically what kind of behavior is permitted.
  • a first determination condition and a second determination condition are predetermined as determination conditions.
  • the patient terminal 20 When it is determined that the measured value satisfies the first determination condition, the patient terminal 20 notifies the user of a first action related to lifestyle habits that can be selected by the user.
  • the patient terminal 20 when it is determined that the measured value satisfies the second determination condition, the patient terminal 20 notifies the user of a second behavior related to lifestyle that can be selected by the user. In this way, by enabling relaxation of restrictions on lifestyle habits according to a plurality of determination conditions, detailed lifestyle management according to the user's disease state becomes possible.
  • the first determination condition is, for example, a strict determination condition with a large degree of relaxation of restrictions
  • the second determination condition is, for example, the first determination condition with a lower degree of relaxation of restrictions than when the first determination condition is achieved.
  • a determination condition that is easier to achieve may be used.
  • the patient terminal 20 acquires measured values from the measuring device 10 that measures the user's biological information. Therefore, the measured value measured by the measuring device 10 can be obtained in real time.
  • the patient terminal 20 and the measuring device 10 cannot communicate directly, the patient terminal 20 acquires the measured values of biological information via a storage medium such as a USB (Universal Serial Bus) memory or another device. good too.
  • a storage medium such as a USB (Universal Serial Bus) memory or another device. good too.
  • ⁇ Second embodiment> it is determined whether or not the TIR of the measured value of the patient 91 in the measurement period satisfies the predetermined determination condition, and notification is given that the restriction on lifestyle habits can be relaxed.
  • notification decisions may not be based on the TIR of the measurements. For example, based on the average value of the measured values of the patient 91 during the measurement period, it may be notified that the restrictions on lifestyle habits can be relaxed.
  • a configuration for performing such processing will be described below. The same processing and configuration as those of the first embodiment are assigned the same reference numerals as those of the first embodiment, and detailed description thereof will be omitted.
  • FIG. 14 is a diagram showing an example of reward determination conditions.
  • the patient terminal 20 uses the average blood sugar level as an example of an index for determining a reward.
  • the average blood glucose level is the average blood glucose level measured during days 1 through 5 of the reward cycle, for example, if the reward cycle is shown in FIG.
  • reward 1 is given when the average blood sugar level is less than 110 mg/dL. If the average blood glucose level is 110 mg/dL or more and less than 120 mg/dL, reward 2 is given. If the average blood glucose level is 120 mg/dL or more and less than 130 mg/dL, reward 3 is given. In this embodiment, the recommended average blood glucose level is less than 140 mg/dL. No reward is given if the average blood glucose level is 130 mg/dL or higher.
  • the relationship between the range of the average blood sugar level and the reward in FIG. 14 may be selected according to .
  • the example of FIG. 14 defines three grades of rewards, there may be fewer or more than three grades of rewards.
  • a range other than the numerical range illustrated in FIG. 14 may be selected as the determination ratio of the measured values.
  • the relationship between the average blood glucose range and the reward may be modified by the healthcare professional 92 based on the condition of the patient 91 .
  • FIG. 15 is a diagram showing an example of the display screen of the patient terminal 20 shown in FIG.
  • the display serving as the output unit 25 displays information regarding changes in the blood sugar level of the patient 91, rewards, and the like.
  • the output unit 25 has a trend graph 51 showing the time transition of the blood sugar level, the latest measured value 52 of the blood sugar level, and a scroll bar 53 for scrolling the trend graph 51 in the output unit 25. Is displayed.
  • the output unit 25 also displays an average value trend 67 indicating the average value of the blood sugar level for each day.
  • the output unit 25 also displays a display area 57 for information related to the reward and an alert box 61 for presenting a message to the patient 91 .
  • a reward selection button 60 is displayed in the display area 57, and in response to the patient 91 pressing the reward selection button 60, the patient terminal 20 displays a reward selection screen (Fig. 10) is the same as in the first embodiment.
  • the patient terminal 20 displays the selected reward 58 and the reward execution time limit 59 in the display area 57 .
  • FIGS. 16A to 16D are flow charts showing an operation example of the patient terminal 20 shown in FIG.
  • the operation of the patient terminal 20 described with reference to FIGS. 16A to 16D corresponds to the information processing method according to this embodiment.
  • the operation of each step in FIGS. 16A to 16D is executed under the control of the control section 21.
  • step S ⁇ b>61 the control unit 21 establishes wireless communication with the measuring device 10 .
  • step S62 the control unit 21 resets the reward cycle. This sets the number of days elapsed to the first day of the 7-day reward cycle.
  • step S63 the control unit 21 determines whether the measuring device 10 stores a measured value that the patient terminal 20 has not yet received. This process is the same as the process of step S3 in FIG. 11A. If there is a measurement value that has not yet been received (YES in step S63), the control unit 21 proceeds to step S64, otherwise (NO in step S63), continues the processing of S63.
  • step S64 the control unit 21 receives the measurement values that have not yet been received from the measuring device 10 and stores them in the storage unit 22.
  • step S65 the control unit 21 causes the output unit 25 to display the received measured value as the latest measured value 52, and updates the trend graph 51.
  • step S66 the control unit 21 determines whether or not a predetermined period has elapsed since the start of the reward cycle.
  • the predetermined period here is the time determined by the timing of updating the display of the average value trend 67 of the output unit 25 .
  • the predetermined period in step S66 is 24 hours, 48 hours, 72 hours, and so on. be. If the predetermined period has elapsed from the start of the reward cycle (YES in step S66), the control unit 21 proceeds to step S67, otherwise (NO in step S66), returns to step S63.
  • step S ⁇ b>67 the control unit 21 calculates the average value of the measured values of blood sugar levels acquired for a predetermined period (for example, one day) and updates the display of the average value trend 67 .
  • step S68 the control unit 21 determines whether 1 day, 2 days, 3 days, or 4 days have passed since the start of the reward cycle, that is, 24 hours, 48 hours, or 72 hours after the start of the reward cycle. Determine if time or 96 hours have passed. If one day, two days, three days, or four days have passed (YES in step S68), the control unit 21 returns to step S63, otherwise (NO in step S68), proceeds to step S69.
  • step S69 the control unit 21 determines whether five days have passed since the start of the reward cycle, that is, whether 120 hours have passed since the start of the reward cycle. If five days have passed (YES in step S69), control unit 21 proceeds to step S70, otherwise (NO in step S69), proceeds to step S86.
  • step S70 the control unit 21 determines whether or not the average blood sugar level calculated in step S67 corresponds to the recommended value described with reference to FIG. In the present embodiment, when the average blood sugar level is less than 140 mg/dL, it is determined to be the recommended level. If the value corresponds to the recommended value (YES in step S70), the controller 21 proceeds to step S72, otherwise (NO in step S70), it proceeds to step S71.
  • step S71 the control unit 21 displays in the alert box 61 that good blood sugar control has not been achieved, for example, "You are one step away from good blood sugar control.” Then, the controller 21 returns to step S63.
  • step S72 the control unit 21 determines whether the changed reward list exists in the cloud 40. This process is similar to step S14 in FIG. 11B. If the changed reward list exists (YES in step S72), the control unit 21 proceeds to step S73, otherwise (NO in step S72), proceeds to step S74.
  • step S73 the control unit 21 downloads the changed reward list from the cloud 40 and updates the reward list stored in the storage unit 22. If the patient terminal 20 cannot communicate with the cloud 40, for example, because the patient terminal 20 exists outside the service area of carrier communication, the process of step S73 may be omitted.
  • step S74 the control unit 21 determines whether or not the average blood sugar level calculated in step S67 satisfies the determination ratio of reward 1 described with reference to FIG. If the determination ratio of reward 1 is satisfied (YES in step S74), the control unit 21 proceeds to step S75, otherwise (NO in step S74), proceeds to step S76.
  • step S75 the control unit 21 displays in the alert box 61 that a reward 1 will be given, for example, "Good control is possible. There is a reward 1.” Then, the controller 21 proceeds to step S81.
  • step S76 the control unit 21 determines whether or not the average blood sugar level calculated in step S67 satisfies the determination ratio of reward 2 described with reference to FIG. If the determination ratio of the reward 2 is satisfied (YES in step S76), the control unit 21 proceeds to step S77, otherwise (NO in step S76), proceeds to step S78.
  • step S77 the control unit 21 displays in the alert box 61 that a reward 2 will be given, for example, "Good control is possible. There is a reward 2.” Then, the controller 21 proceeds to step S81.
  • step S78 the control unit 21 determines whether or not the average blood sugar level calculated in step S67 satisfies the determination ratio of reward 3 described with reference to FIG. If the determination ratio of reward 3 is satisfied (YES in step S78), the control unit 21 proceeds to step S79, otherwise (NO in step S78), proceeds to step S80.
  • step S79 the control unit 21 displays in the alert box 61 that a reward 3 will be given, for example, "Good control is possible. There is a reward 3.” Then, the controller 21 proceeds to step S81.
  • step S80 the controller 21 notifies the alert box 61 of the fact that good blood sugar control has been achieved without giving a reward, such as, for example, "Good blood sugar control is achieved. You are one step away from the reward.” to display. Then, the controller 21 returns to step S63.
  • step S81 the control unit 21 displays a reward selection button 60 in the display area 57 for information related to rewards.
  • step S82 the control unit 21 determines whether or not the reward selection button 60 has been selected by the patient 91. If selected (YES in step S82), the process proceeds to step S83; otherwise (NO in step S82), the process of step S82 is performed again. If the reward selection button 60 is not selected by the patient 91, the controller 21 may proceed to step S63.
  • step S83 the control unit 21 displays the corresponding reward list on the output unit 25.
  • step S84 the control unit 21 determines whether or not the patient 91 has selected a reward. If selected (YES in step S84), the process proceeds to step S85; otherwise (NO in step S84), the process of step S84 is performed again. If the patient 91 does not select the reward, the controller 21 may proceed to step S63.
  • step S85 the control unit 21 displays the reward 58 selected by the patient 91 and the reward implementation deadline 59 in the display area 57 of the information related to the reward. Then, the controller 21 returns to step S63.
  • step S86 the control unit 21 determines whether 6 days have passed since the start of the reward cycle, that is, whether 144 hours have passed since the start of the reward cycle. If only six days have passed (YES in step S86), control unit 21 proceeds to step S87, otherwise (NO in step S86), proceeds to step S89.
  • step S87 the control unit 21 determines whether the patient 91 has obtained a reward.
  • the processing of step S87 is the same as that of S29 in FIG. 11D. If a reward has been obtained (YES in step S87), control unit 21 proceeds to step S88, otherwise (NO in step S87), returns to step S63.
  • step S ⁇ b>88 the control unit 21 hides the display area 57 of information related to the reward in the output unit 25 . Then, the controller 21 returns to step S63.
  • step S89 the control unit 21 determines whether or not the average blood sugar level calculated in step S67 corresponds to the recommended value described with reference to FIG. This mean value corresponds to the average value of measurements that reflect measurements from day 1 through day 7 of the reward cycle, taking into account the effect of the reward. If the value corresponds to the recommended value (YES in step S89), the control unit 21 proceeds to step S90, otherwise (NO in step S89), proceeds to step S91.
  • step S90 the control unit 21 displays in the alert box 61 that good blood sugar control has been achieved, such as "Good blood sugar control.” Then, the controller 21 returns to step S62.
  • step S91 the control unit 21 determines whether the patient 91 has obtained a reward.
  • the processing of step S91 is similar to that of step S33 of FIG. 11D. If a reward has been obtained (YES in step S91), the control unit 21 proceeds to step S93, otherwise (NO in step S91), proceeds to step S92.
  • the processing from step S92 is executed when the average blood sugar level does not reach the recommended value even though seven days have passed without a reward being given.
  • step S93 when the average blood sugar level is good from the first day to the fifth day of the reward cycle and the reward is given, the blood sugar level rises by the seventh day and the average blood sugar level reaches the recommended value. Executed when no more hits.
  • step S92 the control unit 21 displays in the alert box 61 that good blood sugar control has not been achieved, for example, "You are one step away from good blood sugar control.” Then, the controller 21 returns to step S62.
  • step S93 the control unit 21 corrects the reward list stored in the storage unit 22. This process is the same as step S35 in FIG. 11D.
  • step S94 the control unit 21 uploads the relevant data to the cloud 40, and notifies the doctor in charge (medical worker 92) that the average blood sugar level no longer meets the recommended value after the reward is given.
  • the related data here includes the average blood sugar level, the measured value, and the content of the reward selected by the patient 91 .
  • the notification to medical personnel 92 is done via the cloud 40, but may be done by another method such as e-mail.
  • step S95 the control unit 21 says, "You were one step away from good blood sugar control. The reward conditions have been changed, so please consult with your doctor.” An alert box 61 is displayed to the effect that consultation is recommended. Then, the controller 21 returns to step S62.
  • the patient terminal 20 acquires the measured value of the blood sugar level of the user, and determines whether or not the average value of the blood sugar levels measured during the predetermined measurement period satisfies the predetermined determination condition. do.
  • the patient terminal 20 notifies the user that the user's lifestyle habits can be relaxed. In this way, by notifying the user that the restriction on the user's lifestyle can be relaxed based on the user's average blood sugar level, the patient's motivation for treatment is enhanced and maintained, and the treatment is interrupted. can be prevented. Therefore, according to this embodiment, it is possible to support the continuation of the treatment of the patient 91 .
  • the determination may be made based on both the TIR and the average value. As a result, it is possible to provide fine rewards according to the condition of the patient 91 .

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

Ce dispositif de traitement d'informations 20 comprend une unité de commande 21 qui : acquiert une valeur mesurée concernant des informations biologiques considérées comme étant associées au style de vie d'un utilisateur ; évalue si la valeur mesurée mesurée pendant une période de mesure prédéfinie satisfait une condition d'évaluation prédéfinie ; et, lors de l'évaluation que la valeur mesurée satisfait la condition d'évaluation, notifie à l'utilisateur qu'une restriction sur le style de vie de l'utilisateur peut être relâchée.
PCT/JP2021/046120 2021-03-26 2021-12-14 Dispositif de traitement d'informations, système de traitement d'informations, procédé de traitement d'informations et programme WO2022201668A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023508619A JPWO2022201668A1 (fr) 2021-03-26 2021-12-14

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2021054086 2021-03-26
JP2021-054086 2021-03-26

Publications (1)

Publication Number Publication Date
WO2022201668A1 true WO2022201668A1 (fr) 2022-09-29

Family

ID=83396592

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2021/046120 WO2022201668A1 (fr) 2021-03-26 2021-12-14 Dispositif de traitement d'informations, système de traitement d'informations, procédé de traitement d'informations et programme

Country Status (2)

Country Link
JP (1) JPWO2022201668A1 (fr)
WO (1) WO2022201668A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002149830A (ja) * 2000-11-13 2002-05-24 Matsushita Electric Ind Co Ltd 健康管理方法、アドバイス装置および健康管理システム
JP2017040981A (ja) * 2015-08-17 2017-02-23 国立大学法人東北大学 健康情報処理装置、健康情報処理方法、健康情報処理プログラム、健康情報表示装置、健康情報表示方法、及び健康情報表示プログラム
JP2021009446A (ja) * 2019-06-28 2021-01-28 キリンホールディングス株式会社 栄養指導システム及びこれに用いるコンピュータプログラム

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002149830A (ja) * 2000-11-13 2002-05-24 Matsushita Electric Ind Co Ltd 健康管理方法、アドバイス装置および健康管理システム
JP2017040981A (ja) * 2015-08-17 2017-02-23 国立大学法人東北大学 健康情報処理装置、健康情報処理方法、健康情報処理プログラム、健康情報表示装置、健康情報表示方法、及び健康情報表示プログラム
JP2021009446A (ja) * 2019-06-28 2021-01-28 キリンホールディングス株式会社 栄養指導システム及びこれに用いるコンピュータプログラム

Also Published As

Publication number Publication date
JPWO2022201668A1 (fr) 2022-09-29

Similar Documents

Publication Publication Date Title
JP7443235B2 (ja) 意思決定支援のシステムおよび方法
JP6461885B2 (ja) 糖尿病管理のための分析物試験方法及びデバイス
JP7384362B2 (ja) 情報処理方法及び情報処理装置
RU2472427C2 (ru) Мобильное устройство, способ и система для обработки факторов, влияющих на уровень сахара в крови
JP5926517B2 (ja) 個人の健康およびウェルネスの管理のためのシステムおよび、その命令を含むコンピュータプログラムを格納した非一時的コンピュータ可読記憶媒体
US9913599B2 (en) Software applications residing on handheld analyte determining devices
JP5531711B2 (ja) 健康管理支援装置、健康管理支援システムおよび健康管理支援プログラム
WO2018191700A1 (fr) Systèmes et procédés de gestion de maladie chronique à l'aide de données d'analyte et de patient
US11610685B2 (en) Methods and systems for cognitive behavioral therapy
Fioravanti et al. Automatic messaging for improving patients engagement in diabetes management: an exploratory study
Martinez-Millana et al. App features for type 1 diabetes support and patient empowerment: systematic literature review and benchmark comparison
KR102124249B1 (ko) 건강 관련 앱과 웨어러블 기기를 이용한 성인초기 대상자를 위한 대사증후군 예방 프로그램
KR20030014387A (ko) 개인 건강상태 관리 시스템
US20070068539A1 (en) Internet based health management system for identifying and minimizing risk factors contributing to metabolic syndrome
Jones et al. Determinants of longitudinal adherence in smartphone-based self-tracking for chronic health conditions: evidence from axial spondyloarthritis
JP2007034744A (ja) アドバイスフォローアップシステム及びアドバイスフォローアップ方法
WO2022201668A1 (fr) Dispositif de traitement d'informations, système de traitement d'informations, procédé de traitement d'informations et programme
JP6330966B1 (ja) インスリン投与量調整装置およびインスリン投与量調整方法
WO2022244608A1 (fr) Dispositif de traitement d'informations, système de traitement d'informations, procédé de traitement d'informations et programme
Nourse et al. Characteristics of smart health ecosystems that support self-care among people with heart failure: scoping review
JP2002197200A (ja) インターネットを利用した疾病管理システム
JP7214174B1 (ja) 医療支援装置、医療支援装置の動作方法、及びプログラム
JP2024051343A (ja) 診療対象者情報管理システム及び診療対象者情報管理プログラム
JP2023143416A (ja) 警報装置、警報方法、及びプログラム
JP2021167995A (ja) アドバイス装置、アドバイス方法、およびプログラム

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21933260

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2023508619

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21933260

Country of ref document: EP

Kind code of ref document: A1